This component of the program is made possible through Sanofi Cares North America. M05.60, M05.611, M05.612, M05.619, M05.621, M05.622, M05.629, M05.631, M05.632, M05.639, M05.641, M05.642, M05.649, M05.651, M05.652, M05.659, M05.661, M05.662, M05.669, M05.671, M05.672, M05.679, M05.69, M05.70, M05.711, M05.712, M05.719, M05.721, M05.722, M05.729, M05.731, M05.732, M05.739, M05.741, M05.742, M05.749, M05.751, M05.752, M05.759, M05.761, M05.762, M05.769, M05.771, M05.772, M05.779, M05.79, M05.80, M05.811, M05.812, M05.819, M05.821, M05.822, M05.829, M05.831, M05.832, M05.839, M05.841, M05.842, M05.849, M05.851, M05.852, M05.859, M05.861, M05.862, M05.869, M05.871, M05.872, M05.879, M05.89, M05.9, M06.00, M06.011, M06.012, M06.019, M06.021, M06.022, M06.029, M06.031, M06.032, M06.039, M06.041, M06.042, M06.049, M06.051, M06.052, M06.059, M06.061, M06.062, M06.069, M06.071, M06.072, M06.079, M06.08, M06.09, M06.4, M06.80, M06.811, M06.812, M06.819, M06.821, M06.822, M06.829, M06.831, M06.832, M06.839, M06.841, M06.842, M06.849, M06.851, M06.852, M06.859, M06.861, M06.862, M06.869, M06.871, M06.872, M06.879, M06.88, M06.89, M06.9, M08.00, M08.011, M08.012, M08.019, M08.021, M08.022, M08.029, M08.031, M08.032, M08.039, M08.041, M08.042, M08.049, M08.051, M08.052, M08.059, M08.061, M08.062, M08.069, M08.071, M08.072, M08.079, M08.09, M08.20, M08.211, M08.212, M08.219, M08.221, M08.222, M08.229, M08.231, M08.232, M08.239, M08.241, M08.242, M08.249, M08.251, M08.252, M08.259, M08.261, M08.262, M08.269, M08.271, M08.272, M08.279, M08.28, M08.29, M08.40, M08.411, M08.412, M08.419, M08.421, M08.422, M08.429, M08.431, M08.432, M08.439, M08.441, M08.442, M08.449, M08.451, M08.452, M08.459, M08.461, M08.462, M08.469, M08.471, M08.472, M08.479 Rheumatoid arthritis (RA) is an inflammatory disorder in which the immune system attacks its own tissues. Are there any drug plans that pay for plaquenil Malaria resistance to chloroquine Financial criteria for patient assistance. In order to meet the financial eligibility criteria for receiving Sanofi medication at no cost, you must have an annual household income of ≤ 250% of the current Federal Poverty Level. Patient Assistance Connection Financial Eligibility for uninsured or functionally uninsured patients Determine. This is a copay assistance program for patients that have health insurance. The patient's insurance must cover the qualifying medication that they are seeking assistance for. Patient with Medicare Part D will be considered on a case by case basis. Patients must be at or below 400-500% of the federal poverty level. Upon receipt of completed application, prescription from physician, and approval of application, medication will be shipped directly to the physician's office from the distribution center. The patient is eligible for assistance for 12 months. If additional assistance is requested, a new application must be submitted to the hotline. The following information is intended to supplement, not substitute for, the expertise and judgment of your physician, pharmacist or other healthcare professional. RA is a chronic disease that affects the immune system. Patient assistance program for plaquenil Co-pay Cards and Financial Assistance for Arthritis., Patient Assistance Information Lupus medications chloroquineHydroxychloroquine vs malarone HYDROXYCHLOROQUINE - ORAL hi-DROX-ee-KLOR-oh-kwin COMMON BRAND NAMES Plaquenil. Uses. This medication is used to treat rheumatoid arthritis and lupus; and to treat or prevent malaria. How To Use. Take this medication with food to prevent stomach upset. Take this medication exactly as prescribed. Do not stop taking it without consulting your doctor. PLAQUENIL Patient Assistance Program. Sanofi-Aventis Patient Assistance Program -. PAN Foundation - Systemic Lupus Erythematosus. Hydroxychloroquine is in a class of medications that was first used to prevent and treat malaria. Today, it is used to treat rheumatoid arthritis, some symptoms of lupus, childhood arthritis or juvenile idiopathic arthritis and other autoimmune diseases. It is not clear why hydroxychloroquine is effective at treating autoimmune diseases. As the nation’s fastest-growing pharmacy program, Prescription Hope can obtain Plaquenil for patients for the set price of $50.00 per month. In addition, Prescription Hope can also obtain medications from a list of 1,500 FDA-approved medicines, all for the set price of $50.00 per month per medication. Drug Name Brand Name Manufacturer Program Contact Information Abatacept Orencia® Bristol‐Myers Squibb The ORENCIA® abatacept Promise Program™ 1‐800‐ORENCIA Adalimumab Humira® Abbott Immunology Patient Assistance Application for HUMIRA® 1‐866‐4‐HUMIRA Canada 1‐866‐848‐6472 Alendronate Fosamax® Merck The Merck Patient Assistance Program.